Commercial diagnosis
Research and argument design for agency margin intelligence.
Strategy dossier · Independent portfolio project
The case for an off night.
How a premium skincare concept turned restraint into a commercial position without borrowing clinical proof it did not have.
INTERVAL · Lipid Concentrate 01$165 / 50 mL illustrative U.S. offer
Why this project exists
The third case had to prove a different kind of difficulty.
ScopeSignal made an invisible B2B cost visible. ASTER justified premium hardware through engineering and fit. INTERVAL adds the harder beauty problem: a crowded market, ingredient-literate buyers, premium pricing and almost no room for careless proof.
Engineered product value
Premium durable-goods positioning through mechanism and fit.
Beauty proof discipline
Ingredient research, compliance boundaries and luxury DTC execution.
A sophisticated category
The buyer already knows ceramides. That is the problem.
Barrier language is everywhere, from accessible $45 moisturizers to prestige creams above $300. Another “science-backed barrier cream” would enter the page sounding familiar before the bottle was even seen.
Dieux Instant Angel$45Accessible lipid-rich transparency
Tatcha Indigo$94Luxury overnight ritual
SkinCeuticals 2:4:2$155Patented ratio and clinical proof
Prestige ceiling$300+Proprietary-complex luxury
The opening was a role, not an ingredient.
INTERVAL would not claim a better ratio than SkinCeuticals, more testing than Dieux or more mystique than prestige brands. It would own the night between actives: a clear usage role competitors mention but do not organize the entire brand around.
What public discussions revealed
The anxiety is not only discomfort. It is not knowing what to do next.
Across skincare discussions, people describe over-exfoliation, products that suddenly sting and the fear of making things worse. The repeated instruction is simple: go back to basics. The commercial opportunity was to make that restraint feel deliberate rather than defeated.
“Everything I apply burns.”Recognition language
“I do not want to make it worse.”Decision anxiety
“Should I go back to basics?”Desired direction
The category contradiction
Recovery becomes another thing to add.
When the routine feels least tolerant of complexity, the market often answers with another serum, booster or active-rich cream. The page needed to reverse the direction of value.
Category reflex
Add another corrective step.
More ingredients, more claims and more decisions arrive at the exact moment the buyer wants certainty.
vs.
INTERVAL position
Plan a night that asks less.
One product, one job and a defined place between active nights.
UMP to UMS
The mechanism is a sequence decision before it is a formula claim.
That distinction kept the concept ownable without pretending common lipid classes were proprietary.
The Recovery Interval
Your active routine, with room to recover.
A scheduled active-free night built around a fragrance-free concentrate designed with ceramides, cholesterol and fatty acids.
1
Stop adding actives for one night.The mechanism begins with sequencing, not a miracle ingredient.
2
Return a focused lipid system.Three principal lipid classes give the formula a rational direction.
3
Resume with a routine that feels intelligible.The desired outcome is confidence and comfort, not an invented clinical promise.
Concept formula studyClaim only what the evidence can carry
The proof boundary became part of the strategy.
Category literature can explain why ceramides, cholesterol and fatty acids belong in the conversation. It cannot prove what an unmanufactured concept does on a person's skin.
Barrier lipid classesSupported
Named literature supports the role of ceramides, cholesterol and free fatty acids in the stratum corneum.
Formula directionIllustrative
The concept is designed around those classes and excludes retinoids, exfoliating acids, fragrance and essential oils.
Finished-product performanceNot available
No stability, safety, instrumentation or consumer study exists. No percentage or timeline appears in the page.
Testimonials and endorsementsNot available
No invented customer, dermatologist, publication logo or before-and-after asset is used.
Five decisions before purchase
The page does not jump from pain to bottle.
Each section earns one belief the buyer needs before $165 can feel coherent.
An effective routine can still ask too much on some nights.
Recovery does not need another strong active.
A planned interval is sophistication, not retreat.
The three-lipid direction is rational without clinical theatre.
One clear job can justify a premium ritual.
Branded heavy selling
The copy does the work without making the page feel like a letter.
The structure follows a medium-long PDP: one idea per mobile section, mechanism before price justification and proof boundaries before the final offer.
01Recognition heroName the off night, show the product and make the first purchase path complete.
02Category contradictionSkincare became more effective while routines became more aggressive.
03Audience mirrorShow how complexity appears in an active-heavy routine without diagnosing the reader.
04Recovery IntervalReveal the sequence mechanism and connect it to the product role.
05Three-lipid rationaleUse named sources while separating category evidence from product proof.
06Exclusions and ritualTranslate restraint into a tangible formula and usage experience.
07Proof standardState what is known, what is illustrative and what requires testing.
08Offer and FAQPresent $165 once the buyer can explain what the product is for.
Luxury without the beige spa
Quiet, dark and materially precise.
The visual system moves away from both clinical white and soft pink beauty codes. Smoked aubergine glass, silver, black plum and controlled lilac light make restraint feel premium rather than empty.
Precision after dark.
Editorial intelligence.High-contrast serif · precise grotesk labels
The strategy ends in a page you can use.
Research, mechanism, claim discipline, offer and art direction were built as one system. The separate consumer page shows the finished decision environment, not another case-study skin.
Evidence and limitations.
Market pagesSkinCeuticals Triple Lipid Restore, Dieux Instant Angel and Tatcha Indigo Overnight Repair. Prices and claims checked August 2026.
Ingredient rationaleWertz, PMID 17872588; Schild et al., PMID 39113291; ceramide ex vivo study, PMID 29411158.
Regulatory boundaryU.S. FDA Cosmetics Labeling Claims and cosmetic versus drug intended use guidance.
Copy architectureStefan Georgi RMBC PDP and Unique Mechanism source transcripts in the ProfitFix Vault.
INTERVAL and Lipid Concentrate 01 are independent portfolio concepts. The product, packaging, formula direction, price and commercial policies are illustrative. This case study does not present a real client engagement, launched cosmetic, clinical test or customer result. Trademark clearance has not been completed.